Related Experiment Video
Updated: Jan 15, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Beyond the Pump: Reframing Cardiogenic Shock in Heart Failure Through a Multisystem Mechanistic Lens
Ameesh Isath1, Akshay S Desai1, Mandeep R Mehra1
1Center for Advanced Heart Disease, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Insights
Cardiogenic shock (CS) in acute-on-chronic heart failure (ACHF) requires new treatments beyond hemodynamics. Understanding ACHF-CS as a distinct shock type is key to improving patient outcomes.
Area of Science:
- Cardiology
- Critical Care Medicine
- Translational Research
Background:
- Current cardiogenic shock (CS) management, primarily hemodynamic optimization, yields poor outcomes for acute-on-chronic heart failure CS (ACHF-CS).
- The STEMI-CS model inadequately represents the complex physiology of ACHF-CS, which involves multisystem dysfunction.
- ACHF-CS is characterized by hemodynamic abnormalities, systemic inflammation, and microcirculatory dysfunction, leading to organ injury despite hemodynamic recovery.
Abstract:
Management of patients with cardiogenic shock (CS) has long focused on hemodynamic optimization, yet outcomes remain poor, particularly for those with acute-on-chronic heart failure (ACHF)-CS. This hemodynamic-centric paradigm is largely derived from ST-segment elevation myocardial infarction (STEMI)-CS, which inadequately captures the complex, multisystem physiology of ACHF-CS. The syndrome of ACHF-CS emerges from the simultaneous convergence of central hemodynamic abnormalities in concert with systemic inflammation and microcirculatory dysfunction. This primed convergence of aberrations fuels ongoing organ injury despite hemodynamic recovery-a phenomenon of hemodynamic dissonance. Unlike the acute and abrupt sequential trajectory of STEMI-CS, ACHF-CS is a distinctive mechanistic process shaped by longer-standing central and peripheral maladaptation with systemic stress at onset. This paper distinguishes ACHF-CS as a distinct shock phenotype, and highlights emerging therapeutic strategies aimed at modifying disease biology beyond a focus on solely rescuing hemodynamics. A mechanism-specific approach is essential to improve outcomes in ACHF-CS.
More Related Videos
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure V: Medical Management
Heart Failure I: Introduction
Cardiomyopathy V: Interprofessional Care

